Nguyen Tuan 4
4 · Arbutus Biopharma Corp · Filed Feb 2, 2026
Research Summary
AI-generated summary of this filing
Arbutus (ABUS) CFO Nguyen Tuan Receives RSU & Option Awards
What Happened
Nguyen Tuan, Chief Financial Officer of Arbutus Biopharma (ABUS), received equity awards on 2026-02-02: 73,500 restricted stock units (RSUs) and 188,400 derivative awards (option-type grant). Both awards are reported as acquisitions at $0.00 (standard for grants). The RSUs convert to one common share per RSU upon vesting; the derivative award is an option-like grant that vests over time.
Key Details
- Transaction date: 2026-02-02; transaction code: A (award/grant). Report filed 2026-02-02 (timely).
- Reported acquisition price: $0.00 for both grants. (F2: filing also references the closing market price on grant date.)
- RSUs: 73,500 RSUs (F1). Vest in three equal annual installments beginning one year from grant; on each vesting date shares will automatically be sold as needed to satisfy tax withholding in a non‑discretionary transaction.
- Derivative/option: 188,400 shares (reported as a derivative) (F3). Vests over four years with 1/48th vesting in substantially equal monthly installments starting one month after grant.
- Shares owned after the transactions: not specified in the provided excerpt of the filing.
- Filing timeliness: Filed same day as the report date (not late).
Context
- RSUs represent a contingent right to receive shares at vesting; the derivative award is an option-style grant that must vest before shares can be acquired.
- The automatic sale for tax withholding (non-discretionary) means some vested shares may be sold immediately to cover taxes—this is administrative, not a discretionary sale by the insider.
- These are standard equity compensation awards to an executive and do not by themselves indicate a buying or selling signal.
Insider Transaction Report
Form 4
Nguyen Tuan
Chief Financial Officer
Transactions
- Award
Common Shares
[F1]2026-02-02+73,500→ 73,500 total - Award
Stock Option (Right to Buy)
[F2][F3]2026-02-02+188,400→ 188,400 totalExercise: $4.39Exp: 2036-02-02→ Common Shares (188,400 underlying)
Footnotes (3)
- [F1]Represents the grant of restricted stock units ("RSUs"), which represent a contingent right to receive one common share for each RSU. The RSUs vest in three equal annual installments beginning one year from the grant date, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, on each vesting date, common shares will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction.
- [F2]Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant.
- [F3]This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date, subject to the Reporting Person's continuous service as of each vesting date.
Signature
/s/ Tuan Nguyen|2026-02-02